Last reviewed · How we verify
NCT03565081
Effects of Progressive Elastic Band Resistance Training
NA trial testing PWS elastic band training group in Prader-Willi Syndrome in 6 participants. Completed in 31 December 2016.
31 December 2016
Quick facts
| Lead sponsor | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 1 February 2016 |
| Primary completion | 31 December 2016 |
| Estimated completion | 31 December 2016 |
Drugs / interventions tested
- PWS elastic band training group
Conditions studied
- Prader-Willi Syndrome — all drugs for Prader-Willi Syndrome →
- Resistance Training — all drugs for Resistance Training →
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Who can join
Adults 18 to 65, any sex, with Prader-Willi Syndrome or Resistance Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Abnormal body composition with increased body fat mass and decreased lean body mass has been found in adults with Prader-Willi syndrome (PWS), contributing to reduced physical capacity and impairment. The aim of this study was to investigate whether progressive elastic band resistance training can improve physical motor performance and regional body composition in adults with PWS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03565081
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prader-Willi Syndrome
Currently open trials in the same condition.
- NCT06877715 — Autistic Symptomatology and Sensory Profile in Children With Prader-Willi Syndrome · recruiting
- NCT06772597 — A Study of Setmelanotide in Patients With Prader-Willi Syndrome · Phase 2 · active not recruiting
- NCT06573723 — Institutional Registry of Rare Diseases · recruiting
- NCT06239116 — A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment · Phase 1, PHASE2 · recruiting
- NCT06144645 — A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS · Phase 3 · active not recruiting
Other Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation trials
Trials by the same sponsor.
- NCT07357142 — Jing Si Herbal Tea as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome · NA · not yet recruiting
- NCT07310797 — Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion · Phase 4 · not yet recruiting
- NCT07472803 — Longitudinal Body Composition Assessment in Breast Cancer Patients · recruiting
- NCT07151963 — Effects of Prolonged Continuous Theta Burst Stimulation in Chemotherapy-induced Peripheral Neuropathy · NA · enrolling by invitation
- NCT06428942 — Low-potassium Content Vegetables in Chronic Kidney Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03565081 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Last refreshed: 21 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03565081.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing